Clinical Focus

• Nuclear Medicine
• Radiology
• PET Scan

Administrative Appointments

• Chair, Department of Radiology - Stanford University School of Medicine (2011 - present)
• Professor (By courtesy), Materials Science & Engineering (2009 - present)
• Director, Canary Center for Cancer Early Detection at Stanford (2009 - present)
• Professor (By courtesy), Bioengineering (2005 - present)
• Director, Molecular Imaging Program at Stanford (MIPS) (2003 - present)

Honors and Awards

• Georg Charles de Hevesy Nuclear Pioneer Award, Society of Nuclear Medicine (SNM) (2011)
• Outstanding Researcher Award, Radiological Society of North America (RSNA) (2009)
• Parmley Prize, American College of Cardiology Foundations (2009)
• Stanford University Endowed Professorship, Virginia and D. K. Ludwig Professor for Clinical Investigation in Cancer Research (2009)
• IOM member, Institute of Medicine of the National Academies. (2008)

Professional Education

Postdoctoral Advisees

Sarah Bohndiek,  Adam Cole,  Eric Gonzalez,  Aileen Hoehne,  Sharon Hori,  Ohad Ilovich,  Michelle James,  Jesse Jokerst,  Khun Keu,  Uma Kota,  Sri Rajasekhar Kothapalli,  Masakatsu Kotsuma,  Zheng Miao,  Camila Mosci,  Natesh Parashurama,  John Ronald,  Arghavan Salles,  Bin Shen,  Dominique Van de Sompel,  Stephanie Van de Ven,  Cristina Zavaleta,  Keren Ziv

Internet Links

• Molecular Imaging Program at Stanford

Current Research Interests

My laboratory focuses on merging advances in molecular biology with those in biomedical imaging to advance the new field of molecular imaging. Methods to image gene expression in living subjects have been developed. Newer approaches to image fundamental cellular events with optical and radiolabeled probes are under active investigation. These imaging approaches are expected to have a fundamental impact in the study of cancer biology, as well as in molecular therapeutics including gene therapy

Clinical Trials

• Assessing Response to Treatment in Non-Hodgkin’s Lymphoma Patients Using 64Cu-DOTA-Rituximab PET/CT Recruiting
• Combined F18 and F18 FDG PET/CT for Evaluation of Malignancy Recruiting
• FLT-PET/CT vs FDG-PET/CT for Therapy Monitoring of Diffuse Large B-cell Lymphoma Recruiting
• Pilot Study to Determine Radioiodide Accumulation and Dosimetry in Breast Cancers Using 124I PET/CT Recruiting
• 18 F-fluoride PET/CT versus 99Tc-MDP Scanning for Detecting Bone Metastases Suspended

Publications

• A brain tumor molecular imaging strategy using a new triple-modality MRI-photoacoustic-Raman nanoparticle. Kircher MF, de la Zerda A, Jokerst JV, Zavaleta CL, Kempen PJ, Mittra E, Pitter K, Huang R, Campos C, Habte F, Sinclair R, Brennan CW, Mellinghoff IK, Holland EC, Gambhir SS. Nat Med. 2012
• A molecular imaging primer: modalities, imaging agents, and applications. James ML, Gambhir SS. Physiol Rev. 2012; 92 (2): 897-965
• A novel clinically translatable fluorescent nanoparticle for targeted molecular imaging of tumors in living subjects. Gao J, Chen K, Luong R, Bouley DM, Mao H, Qiao T, Gambhir SS, Cheng Z. Nano Lett. 2012; 12 (1): 281-6
• Effect of a CCR1 receptor antagonist on systemic trafficking of MSCs and polyethylene particle-associated bone loss. Gibon E, Yao Z, Rao AJ, Zwingenberger S, Batke B, Valladares R, Smith RL, Biswal S, Gambhir SS, Goodman SB. Biomaterials. 2012
• First Experience with Clinical-Grade [(18)F]FPP(RGD) (2): An Automated Multi-step Radiosynthesis for Clinical PET Studies. Chin FT, Shen B, Liu S, Berganos RA, Chang E, Mittra E, Chen X, Gambhir SS. Mol Imaging Biol. 2012; 14 (1): 88-95